OUR PARTNERS

OUR PARTNERS
Laronde, founded in 2017, by Flagship Labs, is building a new biotech company around their modular Endless RNA™ (eRNA) platform – a completely novel way of modulating human biology – supported by a large-scale digital and manufacturing infrastructure, with the bold vision of 100 new medicines within the next decade.
Endless RNA™ (eRNA), is a uniquely engineered RNA that can be programmed to express diverse therapeutic proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery.
In 2021, the JIMCO Life Sciences Fund participated in Laronde’s Series B funding round to advance the development of its eRNA platform and a broad pipeline of programs across a number of therapeutic categories.
The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.
Visit: Laronde
For most of human history, even the tiniest of scratches could prove fatal. Never mind pneumonia, childbirth or surgery, gardening was a potentially deadly pursuit. A graze or scratch could become …
In medical lexicon ‘metabolic syndrome’ (MetS) might not exactly trip from the tongue like ‘heart disease’ or ‘cancer’. Yet, depending on where you live in the world, there could be a …
Jameel Health is continually forging partnerships with leading organizations, researchers, innovators and thinkers in the global biotech and health industries. In 2021, it appointed Prof. James J. …
Healthcare – or rather adequate access to it – is one of the biggest challenges facing society today.
Despite the unprecedented levels of global wealth created by economic development over the past century, millions of people across vast regions of our planet are dying unnecessarily through poor …
The COVID-19 pandemic has been a stark reminder – if any were needed – of humankind’s persistent failure to address one of its most enduring, and potentially destabilizing, challenges – …
Health technology is transforming the way we can diagnose, treat and prevent disease, and has the potential to radically improve access to healthcare on a global scale.
From a longer-term historical perspective, the world we live in is undoubtedly fairer than it has ever been versus, say 100 years ago. In many – if not the majority – of countries across the …
Jameel Health appoints three globally respected scientists as special scientific advisors to join its mission in accelerating access to modern medical care across the global south.
©️ 2020-2023, Meddist Company Limited (Jameel Health). All rights in this Site are fully reserved. Permission to use this site is granted strictly subject to the Terms of Use. The Abdul Latif Jameel name, Jameel Health name; the Abdul Latif Jameel and Jameel Health logotypes and pentagon-shaped graphic are trademarks, or registered trademarks of Abdul Latif Jameel IPR Company Limited.
For medical incidence reporting please email: safety@jameelhealth.com or call +971 4 448 0905